These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20807606)

  • 1. Strategies for targeting tumors and tumor vasculature for cancer therapy.
    Sreeramoju P; Libutti SK
    Adv Genet; 2010; 69():135-52. PubMed ID: 20807606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting strategies in cancer gene therapy.
    Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
    Bauerschmitz GJ; Barker SD; Hemminki A
    Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal cancer therapy: exploiting tumor characteristics.
    Kaasgaard T; Andresen TL
    Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vectors: systemic delivery and tumor targeting.
    Green NK; Seymour LW
    Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral gene delivery for p53.
    Pirollo KF; Xu L; Chang EH
    Curr Opin Mol Ther; 2000 Apr; 2(2):168-75. PubMed ID: 11249638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of therapeutics to the liver: liposomes and viral vectors.
    Di Campli C; Wu J; Zern MA
    Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
    Wagner E; Kircheis R; Walker GF
    Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
    Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
    Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for cancer gene therapy: progress and opportunities.
    Cao S; Cripps A; Wei MQ
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):108-14. PubMed ID: 19671071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted synthetic gene delivery vectors.
    Schaffer DV; Lauffenburger DA
    Curr Opin Mol Ther; 2000 Apr; 2(2):155-61. PubMed ID: 11249636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
    Dufès C; Keith WN; Bilsland A; Proutski I; Uchegbu IF; Schätzlein AG
    Cancer Res; 2005 Sep; 65(18):8079-84. PubMed ID: 16166279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninfectious gene transfer and expression systems for cancer gene therapy.
    Cooper MJ
    Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.